Shame, Shame, Shame

Howard Richman, the former vice president of Biopure, is heading to jail, reports the Associated Press. During a complaint by Securities and Exchange Commission that accused Biopure executives of misleading their investors about their synthetic blood product's chances of being approved, Richman instructed his lawyer to say that he had terminal colon cancer — which he does not have. Richman pled guilty to obstruction of justice and was sentenced to three years in prison.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Oxford Nanopore Technologies is looking into dual listings in London and Hong Kong, according to the South China Morning Post.

The New York Times looks into medical research funding in the US and how the grant system might not be funding the best work.

US lawmakers proposed increasing the National Science Foundation budget, including its facilities account, Science reports.

In PNAS this week: effects of gene deletions on bacterial metabolic networks, genetic responses to sea star wasting disease, and more.